This page shows the latest cardiovascular diseases news and features for those working in and with pharma, biotech and healthcare.
2b study of fesomersen in patients with ESRD, which we believe supports continued advancement of this potential novel anti-thrombotic therapy for patients with renal and cardiovascular diseases.
The World Heart Federation’s annual World Heart Day takes place today, to highlight the actions that individuals can take to prevent and control cardiovascular disease (CVD). ... If we want to prevent cardiovascular diseases, it is time we take care of
In total, IHI will contribute up to 135m to projects funded under IHI call 1, a single-stage call with topics on cancer, neurodegenerative diseases and health data. ... Call 2 includes a total of two topics. The first aims to provide tools for the
He continued: “The results presented today are a result of pushing new boundaries in the treatment of cardiovascular and other ischaemic vascular diseases and address serious unmet needs with the goal ... AstraZeneca and Moderna signed their first
This acquisition is a testament to Prothena’s pioneering work in ATTR amyloidosis and Novo Nordisk’s dedication to advancing new disease-modifying therapies for the benefit of people with cardiovascular ... diseases that are the world’s leading
Bristol Myers Squibb has reported some new analysis for its investigational cardiovascular drug mavacamten in patients with obstructive hypertrophic cardiomyopathy (oHCM). ... Mavacamten represents Bristol Myers Squibb’s ongoing dedication to improving
More from news
Approximately 5 fully matching, plus 104 partially matching documents found.
Cardiovascular diseases (CVD) are the leading cause of death globally, accounting for 32% of all deaths, according to WHO statistics. ... So-Young Kim is VP Head TA Thrombosis &Vascular Diseases, Clinical Development at Bayer AG.
Conditions classified as rare diseases affect a relatively small percentage of people in the world. ... In Qatar, research into genomics and precision medicine is being used to tackle diseases such as obesity, diabetes and cardiovascular disease.
As we continue to follow the science to understand the underlying mechanisms of associated cardiovascular, renal and metabolic diseases, we are working to address shared risk factors and develop solutions designed ... Joris Silon is Senior Vice President,
The main disease areas of focus have understandably been chronic diseases, including obesity, diabetes, cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD). ... A shift in behaviour could be very beneficial for pharma. With
Drug discovery is almost entirely focused on controlling protein activity to treat or cure diseases, using small-molecule or biologics to inhibit or in some cases boost the activity of a ... Big pharma and new start-ups. Arvinas recently attracted a $750m
More from intelligence
Approximately 0 fully matching, plus 21 partially matching documents found.
Initially, she worked on the research and development of new drugs in cardiovascular and metabolic diseases before specialising in oncology and onco-haematology.
Most recently, he led Bristol-Myers Squibb’s US innovative medicines unit, where he managed a team of over 1000 people focused on immunology and cardiovascular diseases.
Under Bahija’s leadership, MedImmune significantly boosted its pipeline, expanding from 40 to more than 130 molecules in research and development targeting cancer; respiratory, inflammation, and autoimmunity; cardiovascular, renal and metabolic;
Prior to this, Dr Lee was therapeutic area head for cardiovascular, metabolic, respiratory and infectious disease programmes at Genentech. ... Meanwhile, Dr Tripuraneni (pictured left) brings over 10 years of medical affairs expertise in a variety of
therapy and other treatments for cardiovascular diseases.”. ... for the further development of Cardio3 BioSciences' future projects in regenerative therapies and cardiovascular diseases.”.
More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.
Expect a growing debate about the poor health outcomes for patients with major diseases such as cancer, cardiovascular disease and more.
Many years in the making, the first CVDPREVENT audit report, published recently, gives a detailed snapshot of how those with cardiovascular diseases (CVD) are identified, diagnosed, and managed across England. ... This first CVDPREVENT audit is a
Further to this, the tests used to diagnose cardiac diseases function differently between men and women. ... However, once these trials are divided up into specific diseases the underrepresentation becomes clearer, especially in the fields of
September 29th is World Heart Day, a day dedicated to raising awareness about cardiovascular diseases and how everyone can take steps to prevent them. ... Cardiovascular diseases affect ethnic minorities more than white people, with South Asians being
Many years in the making, the first CVDPREVENT audit report, published recently, gives a detailed snapshot of how those with cardiovascular diseases (CVD) are identified, diagnosed, and managed across England. ... COVID-19 has changed the way we must
More from PMHub
Approximately 0 fully matching, plus 10 partially matching documents found.
JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...